MONTREAL, Feb. 12, 2013 /CNW Telbec/ - Doctors Marc Mullie and Gordon Balazsi are among the most experienced laser surgeons in the world. Over the past twenty years, they have performed over 100,000 procedures and have taught their technique to many colleagues from here and elsewhere. Today, they maintain their desire to offer the best that progress and technology have to offer. This morning, they explain their technique in detail, with celebrity guest Sonia Benezra, who has benefitted from this surgery. Not only can Doctors Mullie and Balazsi discuss this new treatment because they practice it, they were also the first in Canada to receive the treatment as patients during a trip to Japan in June 2012.
Specialists in refractive surgery, i.e. laser correction of Myopia, Astigmatism and Hyperopia, Drs. Mullie and Balazsi will now treat Presbyopia with a safe and proven new technique. A first in Quebec.
Presbyopia is currently affects approximately 53% of Canadians, i.e. 17 million people; this number
is expected to increase over time. - Dr. Gordon Balazsi
Presbyopia is an aging process that causes a loss of close-up vision and which affects men and women over age 40. It is caused by changes in the lens of the eye that reduce its elasticity. The eye loses its ability to focus on a close-up image. At this stage, those with Presbyopia require reading glasses for most close-up visual tasks, such as reading a list of ingredients, a text message, a menu, or working on a computer.
Patients want a reliable solution that will allow them to read their mobile device or check their watch without needing reading glasses; from now on, with this new technology, our patients will benefit from a truly lasting solution. - Dr. Marc Mullie
The first in Quebec and the first two Canadians to have received this vision correction, Drs. Mullie and Balazsi underwent the procedure themselves in Asia and can attest to the remarkable advantages of this new approach. Effective, safe and discreet, it is the culmination of ten years of research and development. Approved by Health Canada in September 2012, the Kamra implant is shaped like a ring, measures just 3.8 mm wide, with a central opening of just 1.6 mm, and is one tenth the thickness of a sheet of paper. It is placed in the cornea, the transparent surface of the ocular globe, in front of the pupil, not inside the eye. It only allows the central rays of light that provide clear vision to pass through, blocking the peripheral rays that blur focus. Thus, this new technology significantly improves near vision, as well as depth of field. It provides easier, more convenient and more comfortable natural vision than other solutions for near vision, without altering distance vision. For further details, please consult www.laservue.ca and www.kamra.com.
Media personality Sonia Benezra describes her experience with the correction of her Presbyopia.
Sonia Benezra is pleased to announce that she will be the new spokesperson for the LASERVUE clinic. Vigilant about her well-being, health, safety and style, the popular star acknowledges that or near vision is very inconvenient, complicates even simple tasks and can provide (possibly unwanted!) clues to one's age. She recently underwent the procedure herself and is very pleased with the results of this new technology. She is happy to spread the word about this small miracle!
|Madame Sonia Benezra, Dr. Gordon Balzsi and Dr. Marc Mullie, as well as patients who have undergone the procedure, are available for interviews.|
Image with caption: "Dr. Gordon Balazsi, accompanied by Sonia Benezra who proudly shares her experience after her surgery KAMRA, a newly available technique in Quebec which corrects presbyopia permanently. Alongside them, Dr. Marc Mullie who operated Mrs. Benezra (CNW Group/Laservue Clinic)". Image available at: http://photos.newswire.ca/images/download/20130212_C5055_PHOTO_EN_23665.jpg
SOURCE: Laservue Clinic
For further information:
Source: Laservue Clinic, 514 738-6777 or 1 888 734-6666, http://www.laservue.ca
Press Relations: Rosemonde Communications, Rosemonde Gingras, 514 458-8355, [email protected]